| Summary: | Background. An urgent task of modern dentistry is to find alternative solutions
for the treatment of patients with gingivitis who have limited opportunities to use antibacterial
therapy due to the possible resistance of a number of microorganisms, allergic reactions,
hepatotoxicity and other factors. In this regard, it seems rational to use in the complex
therapy of chronic generalized catarrhal gingivitis silver-containing drugs that are highly effective
against various gram-positive and gram-negative strains of bacteria, as well as
showing viricidal and fungicidal activity, which makes it possible to sanitize the oral cavity
from pathogenic and conditionally pathogenic microflora. The purpose of the study is to
study the effectiveness of silver-containing drugs in the complex treatment of chronic generalized
catarrhal gingivitis. Materials and methods. A study of the activity of enzymes of
mixed saliva was conducted in order to study the effectiveness of the use of silvercontaining
drugs in the complex treatment of patients with chronic generalized catarrhal
gingivitis. 3 groups of patients of the first period of adulthood were studied. All patients,
with the exception of the third group, were administered medications twice a day for 10
days. Patients of the first group were applied with Vitargol, patients of the second group
with Argogel, patients of the third group (comparison group) were prescribed daily rinses
with 0.05% solution of chlorhexidine bigluconate. 20 practically healthy individuals were
also examined. The results of the study were processed by variational statistical methods
using the Statistica for Windows v 10.0 software package. Results. Lactate dehydrogenase
activity in patients with chronic generalized catarrhal gingivitis after treatment with the
drug "Vitargol" decreased by 21.6% 6 months after treatment, with the use of the drug "Argogel"
– by 36.2%, with the use of 0.05% chlorhexidine – by 31.5%. Aspartate aminotransferase
activity decreased after the same observation period: when using Vitargol by 31%,
when using Argogel – by 31.9%, when using 0.05% of chlorhexidine bigluconate – by
45.8%. Conclusion. The best results were obtained in the group with the use of antiseptic
treatment with 0.05% chlorhexidine bigluconate, however, the silver-containing drugs Argogel
and Vitargol, which have biocidal activity and contribute to the relief of the inflammatory
process in the gum tissues, can serve as the drug of choice for maintenance therapy
in patients with restrictions to antibacterial therapy.
|
|---|